Topic #411 - phase i sbir contract - an imagedx based platform for comprehensive DE-identification of WSI data
Ended Definitive Contract Awarded Last action
- Contract number
- 75N91020C00026
- Awardee
-
Reveal Biosciences Inc. UEI HEEAZ9FXXM13
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $370,804
Award facts
- Opportunity
-
- A solicitation of the national institutes of health (NIH) and the centers for disease control and prevention (CDC) for small business innovation research (sbir) contract proposals Solicitation · PHS20201 · Posted Jun 21, 2019
- Contract value 100% obligated
- $370,804.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 12 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- San Diego, CA 92121, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $370,804 |
About this award
This is a $370,804.00 Phase I Small Business Innovation Research (SBIR) contract awarded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH) at the U.S. Department of Health and Human Services (HHS), to Reveal Biosciences Inc. The contract is for the development of an image-based platform to comprehensively de-identify whole slide imaging (WSI) data for cancer research. This was a total small business set-aside contract. Reveal Biosciences is a computational pathology company that provides AI-enabled imaging technologies to support cancer research and diagnosis.
Quick answers
Who was awarded contract 75N91020C00026?
75N91020C00026 was awarded to Reveal Biosciences Inc. by National Cancer Institute (National Institutes of Health) on September 16, 2020.
How much is contract 75N91020C00026 worth?
The government has obligated $370,804 on 75N91020C00026.
Was contract 75N91020C00026 competed?
The extent of competition for 75N91020C00026 was full and open competition after exclusion of sources. The government received 12 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award